Mainstream

InspireMD signals robust U.S. CGuard Prime launch progress and expands clinical pipeline following $58M capital infusion

InspireMD signals robust U.S. CGuard Prime launch progress and expands clinical pipeline following $58M capital infusion

Post ContentnsprRead More

You might also be interested in reading Injective community approves proposal to cut INJ token supply.

August 5, 2025
In Mainstream